Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis

Drug Development Research

Volumn 76, Issue 7, 2015, Pages 343-353

  Nho, Richard Seonghun ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

aging; idiopathic pulmonary fibrosis; microRNA; reactive oxygen species

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; FREE RADICAL; INSULIN; MICRORNA; MICRORNA 1; MICRORNA 122; MICRORNA 145; MICRORNA 154; MICRORNA 155; MICRORNA 200A; MICRORNA 200C; MICRORNA 206; MICRORNA 21; MICRORNA 26; MICRORNA 29; MICRORNA 30; MICRORNA 326; MICRORNA 375; MICRORNA 96; MICRORNA LET 7D; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

3' UNTRANSLATED REGION; AGING; ARTICLE; BIOGENESIS; CELL AGING; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; DNA REPAIR; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENE OVEREXPRESSION; HUMAN; LUNG FIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; SENESCENCE; SIGNAL TRANSDUCTION; STRESS; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; GENETICS; IDIOPATHIC PULMONARY FIBROSIS; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROCEDURES;

AGING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MICRORNAS; MODELS, GENETIC; MOLECULAR TARGETED THERAPY;

EID: 84945466113     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21272     Document Type: Article

References (123)

1. Abe M, Bonini NM., MicroRNAs and neurodegeneration: role and impact. 2013. Trends Cell Biol 23: 30-36.
2. American Thoracic Society, European Respiratory Society. 2000. Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement. Am J Respir Crit Care Med 161 (pt 1): 646-664.
3. Basset F, Ferrans VJ, Soler P, Takemura T, Fukuda Y, Crystal RG., 1986. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 122: 443-461.
4. Baumeister R, Schaffitzel E, Hertweck M., 2006. Endocrine signaling in Caenorhabditis elegans controls stress response and longevity. J Endocrinol 190: 191-202.
5. Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, et al., 2012. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA. 109: 17615-17620.
6. Bluher M, Kahn BB, Kahn CR., 2003. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572-574.
7. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, Offord KP., 1998. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157: 199-203.
8. Boehm M, Slack F., 2005. A developmental timing microRNA and its target regulate life span in C. elegans. Science 310: 1954-1957.
9. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et al., 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
10. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, et al., 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
11. Cataldi A, Di Giulio C., 2009. "Oxygen supply" as modulator of aging processes: hypoxia and hyperoxia models for aging studies. Curr Aging Sci 2: 95-102.
12. Chabot S, Teissié J, Golzio M., 2015. Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR. Adv Drug Deliv Rev 81: 161-168.
13. Chiacchiera F, Simone C., 2010. The AMPK-FoxO3A axis as a target for cancer treatment. Cell Cycle 9: 1091-1096.
14. Chiba T, Yamaza H, Shimokawa I., 2007. Role of insulin and growth hormone/insulin-like growth factor-I signaling in lifespan extension: rodent longevity models for studying aging and calorie restriction. Curr Genomics 8: 423-428.
15. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lü J., 2011. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294.
16. Das S, Kumar M, Negi V, Pattnaik B, Prakash YS, Agrawal A, Ghosh B., 2014. MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis. Am J Respir Cell Mol Biol 50: 882-892.
17. Dattaroy D, Pourhoseini S, Das S, Alhasson F, Seth RK, Nagarkatti M, Michelotti GA, Diehl AM, Chatterjee S., 2014. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 308: G298-G312.
18. de Lencastre A, Pincus Z, Zhou K, Kato M, Lee SS, Slack FJ., 2010. MicroRNAs both promote and antagonize longevity in C. elegans. Curr Biol 20: 2159-2168.
19. Di Giulio C., 2013. Is intermittent hypoxia a cause of aging? COPD 10: 542-544.
20. Eacker SM, Dawson TM, Dawson VL., 2009. Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 10: 837-841.
21. Fattman CL, Chang LY, Termin TA, Petersen L, Enghild JJ, Oury TD., 2003. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 35: 763-771.
22. Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, Masugi Y., 1987. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 126: 171-182.
23. Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, Angelini C, Vergani L, Novelli G, Botta A., 2010. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med 8: 48.
24. Gao F, Kinnula VL, Myllärniemi M, Oury TD., 2008. Extracelluar superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 10: 343-354.
25. Gay SE, Kazerooni EA, Toews GB, Lynch JP 3rd, Gross BH, Cascade PN, et al., 1998. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 157: 1063-1072.
26. Hampel B, Wagner M, Teis D, Zwerschke W, Huber LA, Jansen-Dürr P., 2005. Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3. Aging Cell 4: 325-330.
27. Harrington LA, Harley CB., 1988. Effect of vitamin E on lifespan and reproduction in Caenorhabditis elegans. Mech Ageing Dev 43: 71-78.
28. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, et al., 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395.
29. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, Thannickal VJ., 2014. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med 6: 231ra47.
30. Hekimi S, Guarente L., 2003. Genetics and the specificity of the aging process. Science 299: 1351-1354.
31. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA., 2000. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28: 1456-1462.
32. Hori YS, Kuno A, Hosoda R, Horio Y., 2013. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One 8: e73875.
33. Horrillo D, Gallardo N, Lauzurica N, Barrus MT, San Frutos MG, Andres A, Ros M, Fernandez-Agullo T., 2000. Development of liver fibrosis during aging: effects of caloric restriction. Physiol Renal Physiol 278: F122-F129.
34. Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M., 2014. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Gene 544: 128-133.
35. Huang J, Gan Q, Han L, Li J, Zhang H, Sun Y, Zhang Z, Tong T., 2008. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploidfibroblasts. PLoS One 3: e1710.
36. Hubmacher D, Apte SS., 2013. The biology of the extracellular matrix: novel insights. Curr Opin Rheumatol 25: 65-70.
37. Ibáñez-Ventoso C, Yang M, Guo S, Robins H, Padgett RW, Driscoll M., 2006. Modulated microRNA expression during adult lifespan in Caenorhabditis elegans. Aging Cell 5: 235-246.
38. Inghilleri S, Morbini P, Campo I, Zorzetto M, Oggionni T, Pozzi E, Luisetti M., 2011. Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. Pulm Med 2011: 421409.
39. Jiang Y, Yin H, Zheng XL., 2010. MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J Cell Physiol 225: 506-511.
40. Jung HJ, Suh Y., 2012. MicroRNA in aging: from discovery to biology. Curr Genomics 13: 548-557.
41. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, et al., 2009. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889.
42. Kenyon CJ., 2010. The genetics of ageing. Nature 464, 504-512.
43. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR., 2007. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 18: 4543-452.
44. Kim J, Takahashi M, Shimizu T, Shirasawa T, Kajita M, Kanayama A, Miyamoto Y., 2008. Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans. Mech Ageing Dev 129: 322-331.
45. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G., 1997. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946.
46. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M., 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
47. Kuhn C, McDonald JA., 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Am J Pathol 138: 1257-1265.
48. Kuhn C III, Boldt J, King TE Jr., Couch E, Vartio T, McDonald JA., 1989. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 140: 1693-1703.
49. Kwekkeboom RF, Lei Z, Bogaards SJ, Aiazian E, Kamp O, Paulus WJ, Sluijter JP, Musters RJ., 2015. Ultrasound and microbubble-induced local delivery of MicroRNA-based therapeutics. Ultrasound Med Biol 41: 163-176.
50. La Rocca G, Badin M, shi B, Xu SQ, Deangelis T, Sepp-Lorenzinoi L, Baserga R., 2009. Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. J Cell Physiol 220: 485-491.
51. Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA., 2008. Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One 3: e3220.
52. Lemieux ME, Yang X, Jardine K, He X, Jacobsen KX, Staines WA, Harper ME, McBurney MW., 2005. The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals. Mech Ageing Dev 126: 1097-105.
53. Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C, Leoncini L, Kauppinen S, Lund AH., 2012. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 31: 5081-5089.
54. Li P, Zhao GQ, Chen TF, Chang JX, Wang HQ, Chen SS, Zhang GJ., 2013. Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis. J Asthma 50: 960-964.
55. Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, et al., 2009. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 58: 2246-2257.
56. Liang H, Gu Y, Li T, Zhang Y, Huangfu L, Hu M, Zhao D, Chen Y, Liu S, Dong Y, et al., 2014. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis 5: e1238.
57. Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu C, Li J, Wang X, Song L., 2010. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5: e15797.
58. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E., 2010. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
59. Liu J, Eischeid AN, Chen XM., 2012. Col1A1 production and apoptotic resistance in TGF-β1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells. PLoS One 7: e51371.
60. Liu JW, Chandra D, Rudd MD, Butler AP, Pallotta V, Brown D, Coffer PJ, Tang DG., 2005. Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene 24: 2020-2031.
61. Lizé M, Klimke A, Dobbelstein M., 2011. MicroRNA-449 in cell fate determination. Cell Cycle 10: 2874-2882.
62. Lizé M, Pilarski S, Dobbelstein M., 2010. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17: 452-458.
63. Ma X, Becker Buscaglia LE, Barker JR, Li Y., 2011. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 3: 159-166.
64. Manoury B, Nenan S, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V., 2005. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res 6: 11.
65. Markesbery WR., 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
66. Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, et al., 2010. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62: 1733-1743.
67. McCarthy JJ., 2008. MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta 1779: 682-691.
68. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T., 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
69. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, et al., 2012. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 47: 879-887.
70. Montgomery RL, Yu G, Latimer PA, Stack C, Robinson K, Dalby CM, Kaminski N, van Rooij E., 2014. MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol Med 6: 1347-1356.
71. Morcos M, Hutter H., 2009. The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease. J Alzheimers Dis 16: 897-908.
72. Nadrous HF, Myers JL, Decker PA, Rye JH., 2005. Idiopathic pulmonary fibrosis in patients younger than 50 years. Mayo Clin Proc 80: 37-40.
73. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D., 2012. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev. 21: 355-361.
74. Nho RS, Hergert P, Kahm J, Jessurun J, Henke C., 2011. Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type I collagen matrix. Am J Pathol 179: 2420-2430.
75. Ota H, Eto M, Ako J, Ogawa S, Iijima K, Akishita M, Ouchi Y., 2009. Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilostazol after drug-eluting stent implantation. J Am Coll Cardiol 53: 2298-2305.
76. Pamplona R, Barja G., 2011. An evolutionary comparative scan for longevity-related oxidative stress resistance mechanisms in homeotherms. Biogerontology 12: 409-435.
77. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, et al., 2010. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220-229.
78. Pandit KV, Milosevic J, Kaminski N., 2011. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157: 191-199.
79. Pandit KV, Milosevic J., 2015. MicroRNA regulatory networks in idiopathic pulmonary fibrosis. Biochem Cell Biol 93: 129-137.
80. Pandit KV, Milosevic J, Kaminski N., 2011. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157: 191-199.
81. Paschalaki KE, Starke RD, Hu Y, Mercado N, Margariti A, Gorgoulis VG, Randi AM, Barnes PJ., 2013. Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. Stem Cells 31: 2813-2826.
82. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, et al., 2013. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 4: 2427.
83. Persengieve S, Kondova I, Otting N, Koeppen AH, Bontrop RE., 2011. Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol Aging 32: 2316.e17-e27.
84. Phillips JP, Campbell SD, Michaud D, Charbonneau M, Hilliker AJ., 1989. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci USA 86: 2761-2765.
85. Pincus Z, Smith-Vikos T, Slack FJ., 2011. MicroRNA Predictors of Longevity in Caenorhabditis elegans. PLoS Genet 7: e1002306.
86. Poon HF, Calabrese V, Scapagnini G, Butterfield DA., 2004. Free radicals and brain aging. Clin Geriatr Med 20: 329-359.
87. Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, et al., 2009. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 4: e6718.
88. Quick KL, Ali SS, Arch R, Xiong C, Wozniak D, Dugan LL., 2008. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging 29: 117-128.
89. Rahman I, Kinnula VL, Gorbunova V, Yao H., 2012. SIRT1 as a therapeutic target in inflammaging of the pulmonary disease. Prev Med 54 (Suppl): S20-S28.
90. Robinson CM, Neary R, Levendale A, Watson CJ, Baugh JA., 2012. Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype. Respir Res 13: 74.
91. Sasaki T, Maier B, Bartke A, Scrable H., 2006. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5: 413-422.
92. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaillé J., 2004. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 14: 1741-1748.
93. Selman M, Pardo A., 2014. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med 189: 1161-1172.
94. Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN, Liu XY, Zhang YY, Li Y, Lin SG, et al., 2009. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 381: 597-601.
95. Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, Wong CY, Leung WK, Sung JJ, Chu KM., 2011. NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 32: 240-245.
96. Song P, Zou MH., 2012. Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems. Free Radic Biol Med 52: 1607-1619.
97. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V., 2010. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5: e9979.
98. Sueblinvong V, Neujahr DC, Mills ST, Roser-Page S, Ritzenthaler JD, Guidot D, Rojas M, Roman J., 2012. Predisposition for disrepair in the aged lung. Am J Med Sci 344: 41-51.
99. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP., 2009. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119: 2758-2771
100. Tardif G, Hum D, Pelletier JP, Duval N, Martel-Pelletier J., 2009. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 10: 148.
101. Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, Jeyaseelan K., 2009. Expression profile of MicroRNAs in young stroke patients. PLoS One 4: e7689.
102. Tan WQ, Wang K, Lv DY, Li PF., 2008. Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J Biol Chem 283: 29730-29739.
103. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS., 2001. Science 292: 107-110.
104. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al., 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
105. Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K, Tanaka T, Iso T, Suga T, Kurabayashi M., 2011. Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 300: L740-L752.
106. van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, Brandt BW, Zwaan BJ, Slagboom PE, Westendorp RG., 2005. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 4: 79-85.
107. Voelkel NF, Mizuno S, Bogaard HJ., 2013. The role of hypoxia in pulmonary vascular diseases: a perspective. Am J Physiol Lung Cell Mol Physiol 304: L457-L465.
108. Waghray M, Cui Z, Horowitz JC, Subramanian IM, Martinez FJ, Toews GB, Thannickal VJ., 2005. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J 19: 854-856.
109. Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, et al., 2012a. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23: 252-265.
110. Wang FZ, Weber F, Croce C, Liu CG, Liao X, Pellett PE., 2008a. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 82: 9065-9074.
111. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, et al., 2008b. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14: 369-381.
112. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM., 2009. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36: 181-188.
113. Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T., 2012b. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res 72: 4037-4046.
114. Wei C, Li L, Kim IK, Sun P, Gupta S., 2014. NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress. Free Radic Res 48: 282-291.
115. Weissler JC., 1989. Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis. Am J Med Sci 297: 91-104.
116. White ES, Lazar MH, Thannickal VJ., 2003. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 201: 343-354.
117. Williams AE, Perry MM, Moschos SA, Lindsay MA., 2007. microRNA expression in the aging mouse lung. BMC Genomics 8: 172.
118. Xiao J, Meng XM, Huang XR, Chung AC, Feng YL, Hui DS, Yu CM, Sung JJ, Lan HY., 2012. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20: 1251-1260.
119. Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, Thannickal VJ, Abraham E, Liu G., 2012. Participation of miR-200 in pulmonary fibrosis. Am J Pathol 180: 484-493.
120. Yates LA, Norbury CJ, Gilbert RJ., 2013. The long and short of microRNA. Cell 153: 516-519.
121. Zhou X, Fan LX, Sweeney WE Jr, Denu JM, Avner ED, Li X., 2013. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J Clin Invest 123: 3084-3098.
122. Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X, Liu CG, Yang JM., 2009. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 5: 816-823.
123. Zou Z, Wu L, Ding H, Wang Y, Zhang Y, Chen X, Chen X, Zhang CY, Zhang Q, Zen K., 2012. MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J Biol Chem 287: 4148-4156.